The promising therapeutic effects of metformin on metabolic reprogramming of cancer-associated fibroblasts in solid tumors
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The promising therapeutic effects of metformin on metabolic reprogramming of cancer-associated fibroblasts in solid tumors
Authors
Keywords
-
Journal
CELLULAR & MOLECULAR BIOLOGY LETTERS
Volume 27, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-07-22
DOI
10.1186/s11658-022-00356-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identifying pathways regulating the oncogenic p53 family member ΔNp63 provides therapeutic avenues for squamous cell carcinoma
- (2022) Zuzana Pokorna et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1)
- (2022) Marijo Bilusic et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Quercetin potential effects against SARS‐CoV ‐2 infection and COVID ‐19‐associated cancer progression by inhibiting mTOR and hypoxia‐inducible factor‐1α ( HIF ‐1α)
- (2022) Hamidreza Zalpoor et al. PHYTOTHERAPY RESEARCH
- Mesenchymal stem cells as a double-edged sword in tumor growth: focusing on MSC-derived cytokines
- (2021) Wenqing Liang et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Autocrine TGF-β in Cancer: Review of the Literature and Caveats in Experimental Analysis
- (2021) Hendrik Ungefroren INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The cancer metabolic reprogramming and immune response
- (2021) Longzheng Xia et al. Molecular Cancer
- Oncometabolite in Cancer: Current Understanding and Challenges
- (2021) Yang Liu et al. CANCER RESEARCH
- Worenine reverses the Warburg effect and inhibits colon cancer cell growth by negatively regulating HIF-1α
- (2021) Lijiang Ji et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- The Role of Cancer-Associated Fibroblasts in Tumor Progression
- (2021) Rushikesh S. Joshi et al. Cancers
- A randomized controlled trial of metformin in women with components of metabolic syndrome: intervention feasibility and effects on adiposity and breast density
- (2021) Edgar Tapia et al. BREAST CANCER RESEARCH AND TREATMENT
- Metformin Decreases 2-HG Production through the MYC-PHGDH Pathway in Suppressing Breast Cancer Cell Proliferation
- (2021) Sehyun Oh et al. Metabolites
- Targeting of the tumor immune microenvironment by metformin
- (2021) Zihong Wu et al. Journal of Cell Communication and Signaling
- Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms
- (2020) Floriane Pelon et al. Nature Communications
- Is Lactate an Oncometabolite? Evidence Supporting a Role for Lactate in the Regulation of Transcriptional Activity of Cancer-Related Genes in MCF7 Breast Cancer Cells
- (2020) Iñigo San-Millán et al. Frontiers in Oncology
- Hexokinase 2 Depletion Confers Sensitization to Metformin and Inhibits Glycolysis in Lung Squamous Cell Carcinoma
- (2020) Wenzheng Guo et al. Frontiers in Oncology
- Unfolded protein response (UPR) integrated signaling networks determine cell fate during hypoxia
- (2020) Sylwia Bartoszewska et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Caveolin‐1 in oncogenic metabolic symbiosis
- (2020) Martina Raudenska et al. INTERNATIONAL JOURNAL OF CANCER
- Metabolic reprogramming and cancer progression
- (2020) Brandon Faubert et al. SCIENCE
- Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
- (2020) Lisa M. Butler et al. ADVANCED DRUG DELIVERY REVIEWS
- Heterogeneity of cancer‐associated fibroblasts: Opportunities for precision medicine
- (2020) Ryu Kanzaki et al. CANCER SCIENCE
- A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling
- (2020) Junbin Qian et al. CELL RESEARCH
- Metformin suppresses HIF‐1α expression in cancer‐associated fibroblasts to prevent tumor‐stromal cross talk in breast cancer
- (2020) Shan Shao et al. FASEB JOURNAL
- Metabolite sensing and signaling in Cancer
- (2020) Yi-Ping Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metformin Induces Autophagy via the AMPK-mTOR Signaling Pathway in Human Hepatocellular Carcinoma Cells
- (2020) Chun Gao et al. Cancer Management and Research
- Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancer
- (2020) Jason R Brown et al. JCI Insight
- Role of Proton-Coupled Monocarboxylate Transporters in Cancer: From Metabolic Crosstalk to Therapeutic Potential
- (2020) Xiangyu Sun et al. Frontiers in Cell and Developmental Biology
- Cancer-Associated Fibroblasts: Accomplices in the Tumor Immune Evasion
- (2020) Marc Hilmi et al. Cancers
- Impact of the Tumor Microenvironment on Tumor Heterogeneity and Consequences for Cancer Cell Plasticity and Stemness
- (2020) Ralf Hass et al. Cancers
- Oxidized ATM-mediated glycolysis enhancement in breast cancer-associated fibroblasts contributes to tumor invasion through lactate as metabolic coupling
- (2019) Kexin Sun et al. EBioMedicine
- Fibroblasts rescue oral squamous cancer cell from metformin-induced apoptosis via alleviating metabolic disbalance and inhibiting AMPK pathway
- (2019) Zhuoyuan Zhang et al. CELL CYCLE
- Metabolic regulation of cell growth and proliferation
- (2019) Jiajun Zhu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The multifaceted effects of metformin on tumor microenvironment
- (2019) Ivana Kurelac et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- HIF-1α mediates hyperglycemia-induced pancreatic cancer glycolysis
- (2019) Liang Cheng et al. Anti-Cancer Agents in Medicinal Chemistry
- Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways
- (2019) José Esparza-López et al. BMC CANCER
- Metformin as an archetype immuno-metabolic adjuvant for cancer immunotherapy
- (2019) Sara Verdura et al. OncoImmunology
- Cell Intrinsic and Extrinsic Mechanisms of Caveolin-1-Enhanced Metastasis
- (2019) America Campos et al. Biomolecules
- Oxidative phosphorylation as a potential therapeutic target for cancer therapy
- (2019) Valentina Sica et al. INTERNATIONAL JOURNAL OF CANCER
- Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy
- (2019) Tongyan Liu et al. Journal of Hematology & Oncology
- mTOR: Role in cancer, metastasis and drug resistance
- (2019) Avaniyapuram Kannan Murugan SEMINARS IN CANCER BIOLOGY
- NK Cell Metabolism and Tumor Microenvironment
- (2019) Iñigo Terrén et al. Frontiers in Immunology
- Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma
- (2019) Oscar Arrieta et al. JAMA Oncology
- The Acidic Tumor Microenvironment as a Driver of Cancer
- (2019) Ebbe Boedtkjer et al. Annual Review of Physiology
- Programmed cell death ligand-1-mediated enhancement of hexokinase 2 expression is inversely related to T-cell effector gene expression in non-small-cell lung cancer
- (2019) Sehui Kim et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Metformin strongly affects transcriptome of peripheral blood cells in healthy individuals
- (2019) Monta Ustinova et al. PLoS One
- Metformin suppresses the proliferation and invasion through NF-kB and MMPs in MCF-7 cell line
- (2019) Nail Besli et al. Turkish Journal of Biochemistry-Turk Biyokimya Dergisi
- Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts
- (2019) Tushar D Bhagat et al. eLife
- 2-Hydroxyglutarate in Cancer Cells
- (2019) Petr Ježek ANTIOXIDANTS & REDOX SIGNALING
- A phase II randomized clinical trial of the effect of metformin versus placebo on progression-free survival in women with metastatic breast cancer receiving standard chemotherapy
- (2019) Isabel Pimentel et al. BREAST
- Glycolytic suppression dramatically changes the intracellular metabolic profile of multiple cancer cell lines in a mitochondrial metabolism-dependent manner
- (2019) Reika Shiratori et al. Scientific Reports
- Transcriptomic changes during TGF-β-mediated differentiation of airway fibroblasts to myofibroblasts
- (2019) Erin Joanne Walker et al. Scientific Reports
- Metformin promotes innate immunity through a conserved PMK-1/p38 MAPK pathway
- (2019) Yi Xiao et al. Virulence
- Biological Role and Therapeutic Potential of IDH Mutations in Cancer
- (2018) Matthew S. Waitkus et al. CANCER CELL
- Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
- (2018) Ana Costa et al. CANCER CELL
- LPA Induces Metabolic Reprogramming in Ovarian Cancer via a Pseudohypoxic Response
- (2018) Ji Hee Ha et al. CANCER RESEARCH
- The breast tumor microenvironment: role in cancer development, progression and response to therapy
- (2018) Suruchi Mittal et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Caveolin-1, cancer and therapy resistance
- (2018) Julia Ketteler et al. INTERNATIONAL JOURNAL OF CANCER
- Reciprocal regulation of eNOS and caveolin-1 functions in endothelial cells
- (2018) Zhenlong Chen et al. MOLECULAR BIOLOGY OF THE CELL
- Metformin Suppresses Tumor Progression by Inactivating Stromal Fibroblasts in Ovarian Cancer
- (2018) Sen Xu et al. MOLECULAR CANCER THERAPEUTICS
- Role of the NFκB-signaling pathway in cancer
- (2018) Longzheng Xia et al. OncoTargets and Therapy
- Metformin-induced caveolin-1 expression promotes T-DM1 drug efficacy in breast cancer cells
- (2018) Yuan-Chiang Chung et al. Scientific Reports
- Cancer-associated Fibroblast-derived IL-6 Promotes Head and Neck Cancer Progression via the Osteopontin-NF-kappa B Signaling Pathway
- (2018) Xing Qin et al. Theranostics
- Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts
- (2018) Angelica Avagliano et al. Biomed Research International
- Metformin blocks myeloid-derived suppressor cell accumulation through AMPK-DACH1-CXCL1 axis
- (2018) Guohui Qin et al. OncoImmunology
- D-2-hydroxyglutarate interferes with HIF-1α stability skewing T-cell metabolism towards oxidative phosphorylation and impairing Th17 polarization
- (2018) Martin Böttcher et al. OncoImmunology
- Influence of the Tumor Microenvironment on Cancer Cells Metabolic Reprogramming
- (2018) Victoire Gouirand et al. Frontiers in Oncology
- Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1
- (2018) Jong-Ho Cha et al. MOLECULAR CELL
- Targeting Mitochondrial Oxidative Phosphorylation Abrogated Irinotecan Resistance in NSCLC
- (2018) Soohyun Lee et al. Scientific Reports
- Downregulation of MCT4 for lactate exchange promotes the cytotoxicity of NK cells in breast carcinoma
- (2018) Yaping Long et al. Cancer Medicine
- Effects of metformin on the PI3K/AKT/FOXO1 pathway in anaplastic thyroid Cancer cell lines
- (2018) Zahra Nozhat et al. DARU-Journal of Pharmaceutical Sciences
- Metabolic Switch in the Tumor Microenvironment Determines Immune Responses to Anti-cancer Therapy
- (2018) Barbara Wegiel et al. Frontiers in Oncology
- Unravelling the Interplay between Extracellular Acidosis and Immune Cells
- (2018) Fernando Erra Díaz et al. MEDIATORS OF INFLAMMATION
- The ERK and JNK pathways in the regulation of metabolic reprogramming
- (2018) Salvatore Papa et al. ONCOGENE
- Metformin suppresses gastric cancer progression through calmodulin‑like protein�3 secreted from tumor‑associated fibroblasts
- (2018) Guangxia Chen et al. ONCOLOGY REPORTS
- Nuclear lactate dehydrogenase A senses ROS to produce α-hydroxybutyrate for HPV-induced cervical tumor growth
- (2018) Yuan Liu et al. Nature Communications
- Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer Cells
- (2018) Don Benjamin et al. Cell Reports
- Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment
- (2018) Chunmei Fu et al. Frontiers in Immunology
- Potent immunosuppressive effects of the oncometabolite R-2-hydroxyglutarate
- (2018) Lorenzo Galluzzi et al. OncoImmunology
- Metabolomics profiling of metformin-mediated metabolic reprogramming bypassing AMPKα
- (2018) Min Yan et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Autophagy and Inflammatory Response in the Tumor Microenvironment
- (2017) Daniel Ngabire et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas
- (2017) Gary Kohanbash et al. JOURNAL OF CLINICAL INVESTIGATION
- Metformin effects on head and neck squamous carcinoma microenvironment: Window of opportunity trial
- (2017) Joseph Curry et al. LARYNGOSCOPE
- Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer
- (2017) Gerald Davies et al. PLoS One
- Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development
- (2017) Lindsay Wilde et al. SEMINARS IN ONCOLOGY
- Metabolic Interactions in the Tumor Microenvironment
- (2017) Costas A. Lyssiotis et al. TRENDS IN CELL BIOLOGY
- Impact of Metabolism in on T-Cell Differentiation and Function and Cross Talk with Tumor Microenvironment
- (2017) Soumaya Kouidhi et al. Frontiers in Immunology
- Attenuation of CD4 + CD25 + Regulatory T Cells in the Tumor Microenvironment by Metformin, a Type 2 Diabetes Drug
- (2017) Yuki Kunisada et al. EBioMedicine
- Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation
- (2017) Peiguo Shi et al. Cell Discovery
- Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol
- (2016) Jessica A. Martinez et al. BMC CANCER
- Combinational strategies of metformin and chemotherapy in cancers
- (2016) Hui-Hui Zhang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The influence of the pre-metastatic niche on breast cancer metastasis
- (2016) Josie Ursini-Siegel et al. CANCER LETTERS
- TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3
- (2016) Rachel A. Hesler et al. CARCINOGENESIS
- Caveolin-1 in the regulation of cell metabolism: a cancer perspective
- (2016) Zeribe Chike Nwosu et al. Molecular Cancer
- Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets
- (2016) Yufang Shi et al. NATURE REVIEWS DRUG DISCOVERY
- The Warburg Effect: How Does it Benefit Cancer Cells?
- (2016) Maria V. Liberti et al. TRENDS IN BIOCHEMICAL SCIENCES
- Intratumoral heterogeneity of the therapeutical response to gemcitabine and metformin
- (2016) Dietmar Zechner et al. Oncotarget
- Cancer: An Oxidative Crosstalk between Solid Tumor Cells and Cancer Associated Fibroblasts
- (2016) Alessandro Arcucci et al. Biomed Research International
- Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia
- (2016) Nicole E. Scharping et al. Cancer Immunology Research
- Fundamentals of cancer metabolism
- (2016) R. J. DeBerardinis et al. Science Advances
- Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: Similarities with oxidative stress, inflammation, Alzheimer's disease, and "Neuron-Glia Metabolic Coupling"
- (2016) Stephanos Pavlides et al. Aging-US
- Caveolin interaction governs Kv1.3 lipid raft targeting
- (2016) Mireia Pérez-Verdaguer et al. Scientific Reports
- The Regulation and Function of Lactate Dehydrogenase A: Therapeutic Potential in Brain Tumor
- (2015) Cara J. Valvona et al. BRAIN PATHOLOGY
- Tumors and Mitochondrial Respiration: A Neglected Connection
- (2015) Andrea Viale et al. CANCER RESEARCH
- Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
- (2015) Chih-Hao Chang et al. CELL
- Effect of Metformin vs Placebo on and Metabolic Factors in NCIC CTG MA.32
- (2015) P. J. Goodwin et al. JNCI-Journal of the National Cancer Institute
- PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
- (2015) Nikolaos Patsoukis et al. Nature Communications
- Saturated fatty acids regulate retinoic acid signalling and suppress tumorigenesis by targeting fatty acid-binding protein 5
- (2015) Liraz Levi et al. Nature Communications
- Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype
- (2015) Elisabet Cuyàs et al. Oncotarget
- Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis
- (2015) Jichang Wang et al. Oncotarget
- Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma
- (2015) Xinke Zhou et al. Oncotarget
- Effect of Metformin vs Placebo on and Metabolic Factors in NCIC CTG MA.32
- (2015) P. J. Goodwin et al. JNCI-Journal of the National Cancer Institute
- Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth
- (2015) Kazuyoshi Shiga et al. Cancers
- A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer
- (2014) Nelma Pértega-Gomes et al. BMC CANCER
- Hypoxia-Inducible Factor/MAZ-Dependent Induction of Caveolin-1 Regulates Colon Permeability through Suppression of Occludin, Leading to Hypoxia-Induced Inflammation
- (2014) Liwei Xie et al. MOLECULAR AND CELLULAR BIOLOGY
- Inhibition of the GTPase Rac1 Mediates the Antimigratory Effects of Metformin in Prostate Cancer Cells
- (2014) B. Dirat et al. MOLECULAR CANCER THERAPEUTICS
- Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth
- (2014) Ubaldo E. Martinez-Outschoorn et al. SEMINARS IN CANCER BIOLOGY
- TGF-beta in CAF-mediated tumor growth and metastasis
- (2014) A. Calon et al. SEMINARS IN CANCER BIOLOGY
- Tumor Microenvironment and Metabolic Synergy in Breast Cancers: Critical Importance of Mitochondrial Fuels and Function
- (2014) Ubaldo Martinez-Outschoorn et al. SEMINARS IN ONCOLOGY
- Value of caveolin-1 in cancer progression and prognosis: Emphasis on cancer-associated fibroblasts, human cancer cells and mechanism of caveolin-1 expression (Review)
- (2014) DALI CHEN et al. Oncology Letters
- Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
- (2014) William W Wheaton et al. eLife
- Anti-inflammatory/antioxidant use in long-term maintenance cancer therapy: a new therapeutic approach to disease progression and recurrence
- (2014) Sarah Crawford Therapeutic Advances in Medical Oncology
- Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer
- (2013) Cecilia Marini et al. CELL CYCLE
- Glucose promotes breast cancer aggression and reduces metformin efficacy
- (2013) Reema Wahdan-Alaswad et al. CELL CYCLE
- Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
- (2013) C. Feig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fatty acids revert the inhibition of respiration caused by the antidiabetic drug metformin to facilitate their mitochondrial β-oxidation
- (2012) M. Mar González-Barroso et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Metformin Reduces Endogenous Reactive Oxygen Species and Associated DNA Damage
- (2012) C. Algire et al. Cancer Prevention Research
- Energy transfer in "parasitic" cancer metabolism
- (2012) Ubaldo E. Martinez-Outschoorn et al. CELL CYCLE
- Mitochondrial metabolism in cancer metastasis
- (2012) Federica Sotgia et al. CELL CYCLE
- Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: Connecting TGF-β signaling with “Warburg-like” cancer metabolism and L-lactate production
- (2012) Carmela Guido et al. CELL CYCLE
- Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects
- (2012) M A Pierotti et al. ONCOGENE
- Targeting the Lactate Transporter MCT1 in Endothelial Cells Inhibits Lactate-Induced HIF-1 Activation and Tumor Angiogenesis
- (2012) Pierre Sonveaux et al. PLoS One
- Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy
- (2012) W-Y Shi et al. Cell Death & Disease
- Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment
- (2011) Casey Trimmer et al. CANCER BIOLOGY & THERAPY
- The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells
- (2011) Alejandro Vazquez-Martin et al. CELL CYCLE
- Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect
- (2011) Ubaldo E. Martinez-Outschoorn et al. CELL CYCLE
- Caveolin-1 is essential for metformin inhibitory effect on IGF1 action in non-small-cell lung cancer cells
- (2011) Barbara Salani et al. FASEB JOURNAL
- The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
- (2011) Maria M. Mihaylova et al. NATURE CELL BIOLOGY
- Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome
- (2011) Z. J. Reitman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ketones and lactate “fuel” tumor growth and metastasis
- (2010) Gloria Bonuccelli et al. CELL CYCLE
- Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution
- (2010) Ubaldo E. Martinez-Outschoorn et al. CELL CYCLE
- Glucose metabolism in cancer cells
- (2010) Alessandro Annibaldi et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Lipid Rafts As a Membrane-Organizing Principle
- (2010) D. Lingwood et al. SCIENCE
- Cancer-associated fibroblasts and tumor growth – bystanders turning into key players
- (2009) Arne Östman et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now